The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase
By W. Hacke, G. Albers, Yasir Al-Rawi, J. Bogousslavsky, A. Dávalos, M. Eliasziw, M. Fischer, A. Furlan, M. Kaste, K. Lees and 2 more. Stroke, 2005
1,093 citations recorded by the source corpus.
Subfields: Epidemiology, Neurology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/7117d37403414f8b9a11f5b285802377ae16da6d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Neurology
Citations in the corpus
- Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association (2013, methodology): “cept of using advanced MR or CT for intravenous fibrinolysis triage in the 3- to 9-hour time window.(349,364) Unfortunately,”